Advair Diskus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Bioequivalence Study Comparing Fluticasone Propionate/Salmeterol 100/50 µg Inhalation Powder With Advair® Diskus 100/50 µg in Asthma Patients
Condition:   Bronchial Asthma Interventions:   Drug: Fluticasone propionate/salmeterol 100/50 µg;   Other: Placebo;   Drug: Advair Diskus 100/50 Dry Powder Inhaler, 60 ACTUAT Sponsor:   Cipla Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2018 Category: Research Source Type: clinical trials

BE Study of Fluticasone Propionate/Salmeterol Inhalation Powder in Asthma Patients
Condition:   Bronchial Asthma Interventions:   Drug: Fluticasone propionate/salmeterol 100/50 µg;   Other: Placebo;   Drug: Advair Diskus 100/50 Dry Powder Inhaler, 60 ACTUAT Sponsor:   Cipla Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2018 Category: Research Source Type: clinical trials

Bioequivalence Study Comparing Fluticasone Propionate/Salmeterol 100/50 µg Inhalation Powder With Advair® Diskus 100/50 µg in Asthma Patients
Condition:   Bronchial Asthma Interventions:   Drug: Fluticasone propionate/salmeterol 100/50 µg;   Other: Placebo;   Drug: Advair Diskus 100/50 Dry Powder Inhaler, 60 ACTUAT Sponsor:   Cipla Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2018 Category: Research Source Type: clinical trials

BE Study of Fluticasone Propionate/Salmeterol Inhalation Powder in Asthma Patients
Condition:   Bronchial Asthma Interventions:   Drug: Fluticasone propionate/salmeterol 100/50 µg;   Other: Placebo;   Drug: Advair Diskus 100/50 Dry Powder Inhaler, 60 ACTUAT Sponsor:   Cipla Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2018 Category: Research Source Type: clinical trials

Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Condition:   Asthma Interventions:   Drug: Fp MDPI;   Drug: FS MDPI;   Drug: Placebo Sponsor:   Teva Branded Pharmaceutical Products, R&D  Inc. Not yet recruiting - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2016 Category: Research Source Type: clinical trials